Vaccinations and Autoimmune Diseases

REFERENCES

• Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune diseases: What is the evidence? Lancet 2003; 362: 1659–1666.
   PubMed Web of Science ®Google Scholar
• Doran MF, Crowson CS, Pond GR, Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study. Arthritis Rheum 2002; 46: 1157–1160.
   Google Scholar
• Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology 2007; 46: 1157–1160.
   PubMed Web of Science ®Google Scholar
• Sowden E, Mitchell WS. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007; 8: 58.
   Google Scholar
• Lanternier F, Henegar C, Mouthon L, Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 2008; 67: 1047.
   PubMed Web of Science ®Google Scholar
• Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 837–838.
   PubMed Web of Science ®Google Scholar
• Ofri D. The emotional epidemiology of H1N1 influenza vaccination. N Engl J Med 2009; 361: 2594–2595.
   Google Scholar
• Stewart AM. Mandatory vaccination of health care workers. N Engl J Med 2009; 361: 2015–2017.
   PubMedGoogle Scholar
• Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing clinical guidelines. West J Med 1999; 170: 348–351.
   PubMedGoogle Scholar
• Hernàn MA, Jic SS. Hepatitis B vaccination and multiple sclerosis: The jury is still out. Pharmacoepidemiol Drug Saf 2006; 15: 653–655. doi: 10.1002/pds.1159
   PubMed Web of Science ®Google Scholar
• Vial T, Descotes J. Autoimmune diseases and vaccination. Eur J Dermatol 2004; 14: 86–90.
   PubMed Web of Science ®Google Scholar
• Rubinstein E. Vaccination and autoimmune diseases: The argument against. IMAJ 2004; 6: 433–435.
   Google Scholar
• N Agmon-Levin, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5: 648–652.
   PubMed Web of Science ®Google Scholar
• Safranek TJ, Lawrence DN, Kurland LT, Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976–1977: Results of a two-state study: Expert Neurology Group. Am J Epidemiol 1991; 133: 940–951.
   PubMed Web of Science ®Google Scholar
• Langmuir AD. Guillain-Barré syndrome: The swine influenza virus vaccine incident in the United States of America, 1976–1977: Preliminary communication. J R Soc Med 1979; 72: 660–669.
   PubMed Web of Science ®Google Scholar
• Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am J Epidemiol 1979; 110: 105–123.
   PubMed Web of Science ®Google Scholar
• Marks JS, Halpin TJ. Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine. JAMA 1980; 243: 2490–2494.
   PubMed Web of Science ®Google Scholar
• Breman JG, Hayner NS. Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976–1977. Am J Epidemiol 1984; 119:880–889.
   PubMed Web of Science ®Google Scholar
• Farrington P, Pugh S, Colville A, A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345: 567–569.
   PubMed Web of Science ®Google Scholar
• Miller E, Waight P, Farrington C, Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001; 84: 227–229. doi: 10.1136/adc.84.3.227
   PubMed Web of Science ®Google Scholar
• Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol 2003; 55: 107–111.
   PubMed Web of Science ®Google Scholar
• F DeStefano, Mullooly JP, Okoro CA, Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001; 108: E112.
   PubMed Web of Science ®Google Scholar
• Hviid A, Stellfield M, Wohlfahrt J, Melbye M. Childhood vaccination and type 1 diabetes. N Engl J Med 2004; 350: 1398–1404.
   PubMed Web of Science ®Google Scholar
• Herroelen L, J de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991; 338:1174–1175.
   PubMed Web of Science ®Google Scholar
• Touze E, Gout O, Verdier-Taillefer MH. The first episode of central nervous system demyelinization and hepatitis B vaccination. Rev Neurol 2000; 156: 242–246.
   PubMed Web of Science ®Google Scholar
• Gout, O, Lyon Caen, O. Sclerotic plaques and vaccination against hepatitis B. Rev Neurol 1998; 154: 205–207.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Zhang SM, Hernan MA, Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 334: 327–332.
   Google Scholar
• Confavreux C, Suissa S, Saddier P, Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001; 344: 319–326.
   PubMed Web of Science ®Google Scholar
• Stratton K, Almario DA, McCormick MC. Editors, Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (Free Executive Summary). 2002. Retrieved from http://www.nap.edu/catalog/10393.html
   Google Scholar
• Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev 2005; 4: 96–100.
   PubMed Web of Science ®Google Scholar
• Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004; 63: 838–842.
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009; 72: 873–880.
   PubMed Web of Science ®Google Scholar
• Mercado U, Acosta H, Avendano L. Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus? J Rheumatol 2006; 33: 1469–1471.
   PubMed Web of Science ®Google Scholar
• Sibley WA, Bamford CR, Laguna JF. Influenza vaccination in patients with multiple sclerosis. JAMA 1976; 236: 1965–1966.
   Google Scholar
• Myers LW, Ellison GW, Lucia M, Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis 1977; 136(Suppl): S546–S554.
   Google Scholar
• Bamford CR, Sibley WA, Laguna JF. Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol 1978; 35: 242–243.
   Google Scholar
• Williams GW, Steinberg AD, Reinertsen JL, Influenza immunization in systemic lupus erythematosus: A double-blind trial. Ann Int Med 1978; 88: 729–734.
   PubMedGoogle Scholar
• Brodman R, Gilfillan R, Glass D, Schur PH. Influenza vaccine response in systemic lupus erythematosus. Ann Int Med 1978; 88: 735–740.
   PubMed Web of Science ®Google Scholar
• Louie JS, Nies KM, Shoji KT, Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Int Med 1978; 88: 790–792.
   PubMed Web of Science ®Google Scholar
• Ristow SC, Douglas RG, Condemi JJ. Influenza vaccination of patients with systemic lupus erythematosus. Ann Int Med 1978; 88: 786–789.
   PubMed Web of Science ®Google Scholar
• Herron A, Dettleff G, Hixon B, Influenza vaccination in patients with rheumatic diseases. JAMA 1979; 242: 53–56.
   PubMed Web of Science ®Google Scholar
• Klippel JH, Karsh J, Stahl NI, A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1321–1325.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Gale E, Visalli N, The immune response to influenza vaccination in diabetic patients. Diabetologia 1986; 29: 850–854.
   Google Scholar
• Diepersloot R, Bouter K, Beyer W, Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 1987; 30: 397–401.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Arduini P, Visalli N, Reduced protection against hepatitis B virus following vaccination in patients with Type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30: 817–819.
   PubMed Web of Science ®Google Scholar
• Battafarano DF, Battafarano NJ, Larsen L, Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998; 41: 1828–1834.
   PubMed Web of Science ®Google Scholar
• A Schattner. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23: 3876–3886.
   PubMed Web of Science ®Google Scholar
• Conti F, Rezai S, Valesini G. Vaccination and autoimmune diseases: Is there still a dilemma? Curr Rheumatol Rev 2007; 3: 79–91.
   Google Scholar
• Gluck T, Muller-Landner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46: 1459–1465.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Abbott GF, Koreishi AF. A woman with respiratory failure and a cavitary lesion in the lung. N Engl J Med 2009; 360: 1770–1779.
   Google Scholar